Chronicle_2A: Chronicle, figure 2A

Chronicle_2AR Documentation

Chronicle, figure 2A

Description

Kaplan-Meier digitized data from Chronicle, figure 2A (PMID 24718885). A reported sample size of 113 for a primary endpoint of DFS in colorectal cancer.

Usage

Chronicle_2A

Format

A data frame of 113 observations and 3 variables:

time event time (in months)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (capecitabine_oxaliplatin, follow_up_only)

Source

Glynne-Jones R, Counsell N, Quirke P, et al. Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. Ann Oncol 2014; 25: 1356–62.

Examples

summary(Chronicle_2A)

kmplot(Chronicle_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.